Oral arguments previously scheduled for Sept. 14 in drugmaker AstraZeneca’s 340B contract pharmacy lawsuit against HHS and HRSA have been rescheduled for Oct. 18. The U.S. District Court for the District of Delaware announced the new date for arguments on Aug. 24.
The news will certainly frustrate 340B providers that are experiencing growing financial losses in the contract pharmacy setting.
Oral arguments previously scheduled for Sept. 14 in drugmaker AstraZeneca’s 340B contract pharmacy lawsuit against HHS and HRSA have been rescheduled for Oct. 18. The U.S. District Court for the District of Delaware announced the new date for arguments on Aug. 24. The news will certainly frustrate 340B providers that are experiencing growing financial losses in the contract pharmacy setting.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.